OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001651407

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc. (CIK 0001651407, EIN 47-2568632) reported revenue of $41,000 for FY2024 (2024-01-01 to 2024-12-31) and net income of -$56.24 million (-$56,240,000) for FY2024 (2024-01-01 to 2024-12-31), as filed in its 10-K filed 2025-03-28 (accession 0001410578-25-000528).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001651407
EIN47-2568632
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_7mhmtycvhv2dspe32k5kq1n83n
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$41,000FY20242024-01-01 to 2024-12-3110-K2025-03-280001410578-25-000528Revenues
Net income-$56,240,000FY20242024-01-01 to 2024-12-3110-K2025-03-280001410578-25-000528NetIncomeLoss
Total assets$7,471,000FY2024as of 2024-12-3110-K2025-03-280001410578-25-000528Assets
Total liabilities$20,096,000FY2024as of 2024-12-3110-K2025-03-280001410578-25-000528Liabilities
Stockholders' equity-$12,625,000FY2024as of 2024-12-3110-K2025-03-280001410578-25-000528StockholdersEquity
Operating cash flow-$31,101,000FY20242024-01-01 to 2024-12-3110-K2025-03-280001410578-25-000528NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.42 per shareFY20242024-01-01 to 2024-12-3110-K2025-03-280001410578-25-000528EarningsPerShareDiluted
Shares outstanding53,640,422 sharesFY2024as of 2024-12-3110-K2025-03-280001410578-25-000528CommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2015-2024, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20242024-01-01 to 2024-12-31$41,00010-K2025-03-280001410578-25-000528
RevenueFY20232023-01-01 to 2023-12-31$103,00010-K2025-03-280001410578-25-000528
RevenueFY20222022-01-01 to 2022-12-31$192,00010-K2024-03-220001410578-24-000283
Net incomeFY20242024-01-01 to 2024-12-31-$56,240,00010-K2025-03-280001410578-25-000528
Net incomeFY20232023-01-01 to 2023-12-31-$51,847,00010-K2025-03-280001410578-25-000528
Net incomeFY20222022-01-01 to 2022-12-31-$62,624,00010-K2024-03-220001410578-24-000283
Net incomeFY20212021-01-01 to 2021-12-31-$56,670,00010-K2023-03-310001410578-23-000565
Net incomeFY20202020-01-01 to 2020-12-31-$23,081,00010-K2022-03-280001410578-22-000556
Net incomeFY20192019-01-01 to 2019-12-31-$24,714,00010-K2021-03-120001104659-21-035291
Net incomeFY20182018-01-01 to 2018-12-31-$36,367,00010-K2020-03-110001104659-20-032004
Net incomeFY20172017-01-01 to 2017-12-31-$22,677,00010-K2019-03-180001144204-19-014409
Net incomeFY20162016-01-01 to 2016-12-31-$22,461,00010-K2018-03-160001144204-18-015101

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2025-05-132025-03-310001410578-25-001233ckpt-20250331x10q.htm
10-K2025-03-282024-12-310001410578-25-000528ckpt-20241231x10k.htm
10-Q2024-11-122024-09-300001410578-24-001885ckpt-20240930x10q.htm
10-Q2024-08-122024-06-300001410578-24-001317ckpt-20240630x10q.htm
10-Q2024-05-102024-03-310001410578-24-000738ckpt-20240331x10q.htm
10-K2024-03-222023-12-310001410578-24-000283ckpt-20231231x10k.htm
10-Q2023-11-132023-09-300001410578-23-002423ckpt-20230930x10q.htm
10-Q2023-08-142023-06-300001410578-23-001903ckpt-20230630x10q.htm
10-Q2023-05-152023-03-310001410578-23-001230ckpt-20230331x10q.htm
10-K2023-03-312022-12-310001410578-23-000565ckpt-20221231x10k.htm
10-Q2022-11-102022-09-300001410578-22-003153ckpt-20220930x10q.htm
10-Q2022-08-122022-06-300001410578-22-002432ckpt-20220630x10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001651407published by the sourcedata.sec.gov/submissions/CIK0001651407.json2026-10-21
Employer Identification Number (EIN) · US-EIN47-2568632published by the sourcedata.sec.gov/submissions/CIK0001651407.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001651407.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001651407.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001651407" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001651407/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001651407/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1651407"}

On SEC EDGAR

About this data